申请人:SHIONOGI & CO., LTD.
公开号:EP2017261A1
公开(公告)日:2009-01-21
This invention provides a compound of the formula (I):
a pharmaceutically acceptable salt or solvate thereof,
wherein
R1 is optionally substituted lower alkyl,
Y is -S(O)n- wherein n is 1 or 2, or -CO-,
R2 is hydrogen or lower alkyl,
R7 is hydrogen or lower alkyl,
X is lower alkylene, lower alkenylene, arylene, cycloalkylene or the like, and
Z is lower alkyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl or the like.
本发明提供了一种式 (I) 的化合物:
其药学上可接受的盐或溶液、
其中
R1 是任选取代的低级烷基、
Y是-S(O)n- 其中n是1或2,或-CO-、
R2 是氢或低级烷基
R7 是氢或低级烷基
X 是低级烯烃、低级烯烃、芳烃、环烷烃或类似物,以及
Z 是低级烷基、任选取代的碳环烷基、任选取代的杂环烷基或类似物。